DC05F01

· Heronova Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DC05F01, covering 2025-03-12 to 2025-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors [Phase 1, Phase 2]

See pricing